CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CELL - IT0005244618 - Common Stock
2.565 EUR
+0.02 (+0.59%)
CELL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 33 industry peers in the Technology Hardware, Storage & Peripherals industry. CELL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CELL is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- CELL had positive earnings in the past year.
- In the past year CELL had a positive cash flow from operations.
- In multiple years CELL reported negative net income over the last 5 years.
- CELL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of CELL (2.60%) is comparable to the rest of the industry.
- CELL's Return On Equity of 4.27% is fine compared to the rest of the industry. CELL outperforms 60.61% of its industry peers.
- The Return On Invested Capital of CELL (4.42%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROIC | 4.42% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Profit Margin value of 3.44%, CELL perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
- In the last couple of years the Profit Margin of CELL has declined.
- CELL has a Operating Margin (4.91%) which is in line with its industry peers.
- CELL's Operating Margin has declined in the last couple of years.
- CELL's Gross Margin of 40.07% is fine compared to the rest of the industry. CELL outperforms 66.67% of its industry peers.
- CELL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% |
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CELL is destroying value.
- The number of shares outstanding for CELL has been reduced compared to 1 year ago.
- Compared to 5 years ago, CELL has less shares outstanding
- Compared to 1 year ago, CELL has an improved debt to assets ratio.
2.2 Solvency
- CELL has an Altman-Z score of 2.34. This is not the best score and indicates that CELL is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.34, CELL is in line with its industry, outperforming 57.58% of the companies in the same industry.
- CELL has a debt to FCF ratio of 2.46. This is a good value and a sign of high solvency as CELL would need 2.46 years to pay back of all of its debts.
- CELL's Debt to FCF ratio of 2.46 is fine compared to the rest of the industry. CELL outperforms 75.76% of its industry peers.
- CELL has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
- CELL has a Debt to Equity ratio of 0.13. This is amongst the best in the industry. CELL outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Altman-Z | 2.34 |
ROIC/WACC0.48
WACC9.23%
2.3 Liquidity
- CELL has a Current Ratio of 2.12. This indicates that CELL is financially healthy and has no problem in meeting its short term obligations.
- CELL has a Current ratio of 2.12. This is in the better half of the industry: CELL outperforms 72.73% of its industry peers.
- A Quick Ratio of 1.33 indicates that CELL should not have too much problems paying its short term obligations.
- The Quick ratio of CELL (1.33) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 60.78% over the past year.
- CELL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.43% yearly.
- The Revenue has been growing slightly by 3.54% in the past year.
- The Revenue has been growing slightly by 3.18% on average over the past years.
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
3.2 Future
- CELL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.47% yearly.
- Based on estimates for the next years, CELL will show a decrease in Revenue. The Revenue will decrease by -0.60% on average per year.
EPS Next Y-15%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.17%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- CELL is valuated reasonably with a Price/Earnings ratio of 9.87.
- Based on the Price/Earnings ratio, CELL is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 27.38. CELL is valued rather cheaply when compared to this.
- Based on the Price/Forward Earnings ratio of 5.99, the valuation of CELL can be described as very cheap.
- Based on the Price/Forward Earnings ratio, CELL is valued cheaply inside the industry as 96.97% of the companies are valued more expensively.
- CELL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.29.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.87 | ||
| Fwd PE | 5.99 |
4.2 Price Multiples
- CELL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CELL is cheaper than 93.94% of the companies in the same industry.
- 100.00% of the companies in the same industry are more expensive than CELL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.76 | ||
| EV/EBITDA | 2.99 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- CELL has a Yearly Dividend Yield of 3.65%.
- Compared to an average industry Dividend Yield of 0.90, CELL pays a better dividend. On top of this CELL pays more dividend than 93.94% of the companies listed in the same industry.
- CELL's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.65% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 34.37% of the earnings are spent on dividend by CELL. This is a low number and sustainable payout ratio.
DP34.37%
EPS Next 2Y2.47%
EPS Next 3YN/A
BIT:CELL (1/16/2026, 11:49:35 AM)
2.565
+0.02 (+0.59%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-05 2025-11-05
Earnings (Next)03-09 2026-03-09
Inst Owners4.94%
Inst Owner ChangeN/A
Ins Owners19.57%
Ins Owner ChangeN/A
Market Cap56.10M
Revenue(TTM)164.26M
Net Income(TTM)5.65M
Analysts82.86
Price Target4.18 (62.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.65% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP34.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.87 | ||
| Fwd PE | 5.99 | ||
| P/S | 0.34 | ||
| P/FCF | 3.76 | ||
| P/OCF | 2.76 | ||
| P/B | 0.42 | ||
| P/tB | 1.03 | ||
| EV/EBITDA | 2.99 |
EPS(TTM)0.26
EY10.14%
EPS(NY)0.43
Fwd EY16.7%
FCF(TTM)0.68
FCFY26.59%
OCF(TTM)0.93
OCFY36.19%
SpS7.51
BVpS6.05
TBVpS2.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROCE | 5.04% | ||
| ROIC | 4.42% | ||
| ROICexc | 5.33% | ||
| ROICexgc | 12.93% | ||
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% | ||
| FCFM | 9.08% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y46.34%
ROICexgc growth 5Y-17.53%
ROICexc growth 3Y77.77%
ROICexc growth 5Y-8.95%
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
F-Score4
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Debt/EBITDA | 0.81 | ||
| Cap/Depr | 39.19% | ||
| Cap/Sales | 3.28% | ||
| Interest Coverage | 2.77 | ||
| Cash Conversion | 93.13% | ||
| Profit Quality | 264.18% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 2.34 |
F-Score4
WACC9.23%
ROIC/WACC0.48
Cap/Depr(3y)26.8%
Cap/Depr(5y)35.01%
Cap/Sales(3y)3.22%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
EPS Next Y-15%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
Revenue Next Year-6.17%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.25%
EBIT growth 3Y54.08%
EBIT growth 5Y-17%
EBIT Next Year25.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1050.19%
FCF growth 3Y4.84%
FCF growth 5Y6.28%
OCF growth 1Y730.91%
OCF growth 3Y4.12%
OCF growth 5Y1.2%
CELLULARLINE SPA / CELL.MI FAQ
What is the ChartMill fundamental rating of CELLULARLINE SPA (CELL.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CELL.MI.
What is the valuation status for CELL stock?
ChartMill assigns a valuation rating of 7 / 10 to CELLULARLINE SPA (CELL.MI). This can be considered as Undervalued.
What is the profitability of CELL stock?
CELLULARLINE SPA (CELL.MI) has a profitability rating of 4 / 10.
What are the PE and PB ratios of CELLULARLINE SPA (CELL.MI) stock?
The Price/Earnings (PE) ratio for CELLULARLINE SPA (CELL.MI) is 9.87 and the Price/Book (PB) ratio is 0.42.
Can you provide the dividend sustainability for CELL stock?
The dividend rating of CELLULARLINE SPA (CELL.MI) is 6 / 10 and the dividend payout ratio is 34.37%.